Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes.

Plafkin C, Singh T, Astor BC, Parajuli S, Bhutani G, Safdar N, Panzer SE.

Transpl Infect Dis. 2018 Aug 13:e12974. doi: 10.1111/tid.12974. [Epub ahead of print]

PMID:
30102820
2.

Risk Factors for Prognosis in Patients With Severely Decreased GFR.

Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC.

Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May.

3.

The feared five fungal infections in kidney transplant recipients: A single-center 20-year experience.

Parajuli S, Wick A, Pandeya S, Astor BC, Smith J, Djamali A, Mandelbrot DA.

Clin Transplant. 2018 Jul;32(7):e13289. doi: 10.1111/ctr.13289. Epub 2018 Jun 19.

PMID:
29782660
4.

BK viremia is not associated with adverse outcomes in the absence of BK nephropathy.

Hertz-Tang AL, Astor BC, Mandelbrot DA, Mohamed MA, Djamali A, Parajuli S.

Clin Transplant. 2018 Jul;32(7):e13283. doi: 10.1111/ctr.13283. Epub 2018 Jun 15.

PMID:
29774593
5.

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation.

Parajuli S, Mandelbrot DA, Muth B, Mohamed M, Garg N, Aziz F, Redfield RR, Zhong W, Astor BC, Djamali A.

Transplant Direct. 2017 Oct 27;3(12):e227. doi: 10.1097/TXD.0000000000000746. eCollection 2017 Dec.

6.

Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection?

Parajuli S, Astor BC, Kaufman D, Muth B, Mohamed M, Garg N, Djamali A, Mandelbrot DA.

Clin Transplant. 2018 Apr;32(4):e13216. doi: 10.1111/ctr.13216. Epub 2018 Feb 23.

PMID:
29394515
7.

Patterns of kidney injury in pediatric nonkidney solid organ transplant recipients.

Williams C, Borges K, Banh T, Vasilevska-Ristovska J, Chanchlani R, Ng VL, Dipchand AI, Solomon M, Hebert D, Kim SJ, Astor BC, Parekh RS.

Am J Transplant. 2018 Jun;18(6):1481-1488. doi: 10.1111/ajt.14638. Epub 2018 Feb 6.

PMID:
29286569
8.

Higher Pretransplantation Hemoglobin A1c Is Associated With Greater Risk of Posttransplant Diabetes Mellitus.

Shin JI, Palta M, Djamali A, Astor BC.

Kidney Int Rep. 2017 Jun 22;2(6):1076-1087. doi: 10.1016/j.ekir.2017.06.006. eCollection 2017 Nov.

9.

Kidney Transplant Recipients With Primary Membranous Glomerulonephritis Have a Higher Risk of Acute Rejection Compared With Other Primary Glomerulonephritides.

Singh T, Astor B, Zhong W, Mandelbrot D, Djamali A, Panzer S.

Transplant Direct. 2017 Oct 18;3(11):e223. doi: 10.1097/TXD.0000000000000736. eCollection 2017 Nov.

10.

Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease.

Jorgenson MR, Descourouez JL, Singh T, Astor BC, Panzer SE.

Pharmacotherapy. 2018 Jan;38(1):51-57. doi: 10.1002/phar.2059. Epub 2017 Dec 18.

PMID:
29136299
11.

Seasonality of mortality and graft failure among kidney transplant recipients in the US - a retrospective study.

Astor BC, Melamed ML, Mandelbrot DA, Djamali A.

Transpl Int. 2018 Mar;31(3):293-301. doi: 10.1111/tri.13047. Epub 2017 Sep 26.

PMID:
28871657
12.

Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection - a retrospective study.

Parajuli S, Arpali E, Astor BC, Djamali A, Aziz F, Redfield RR, Sollinger HW, Kaufman DB, Odorico J, Mandelbrot DA.

Transpl Int. 2018 Jan;31(1):32-37. doi: 10.1111/tri.13007. Epub 2017 Aug 3.

PMID:
28672081
13.

A single center kidney transplant experience among ten Caucasian females with end-stage renal disease due to scleroderma
.

Saxena N, Djamali A, Astor BC, Mohamed M, Mandelbrot D, Parajuli S.

Clin Nephrol. 2017 Jul;88(1):40-44. doi: 10.5414/CN109107.

PMID:
28406085
14.

Association of Pre-Transplant Dialysis Modality and Post-Transplant Outcomes: A Meta-Analysis.

Joachim E, Gardezi AI, Chan MR, Shin JI, Astor BC, Waheed S.

Perit Dial Int. 2017 May-Jun;37(3):259-265. doi: 10.3747/pdi.2016.00011. Epub 2016 Dec 22. Review.

PMID:
28007762
15.

Outcomes in the highest panel reactive antibody recipients of deceased donor kidneys under the new kidney allocation system.

Parajuli S, Redfield RR, Astor BC, Djamali A, Kaufman DB, Mandelbrot DA.

Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12895. Epub 2017 Jan 29.

PMID:
27988992
16.

Incidence and Indications for Late Allograft Pancreatectomy While on Continued Immunosuppression.

Parajuli S, Odorico J, Astor BC, Djamali A, Sollinger H, Redfield R, Kaufman D, Mandelbrot DA.

Transplantation. 2017 Sep;101(9):2228-2234. doi: 10.1097/TP.0000000000001556.

PMID:
27798517
17.

Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.

Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V.

Atherosclerosis. 2016 Oct;253:156-163. doi: 10.1016/j.atherosclerosis.2016.08.028. Epub 2016 Aug 25.

18.

The association of mineral metabolism with vascular access patency.

Rosenberg JE, Astor BC, Deluca HF, Yevzlin AS.

J Vasc Access. 2016 Sep 21;17(5):392-396. doi: 10.5301/jva.5000584. Epub 2016 Jul 23.

PMID:
27470251
19.

In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.

Mohamed M, Parajuli S, Muth B, Astor BC, Panzer SE, Mandelbrot D, Zhong W, Djamali A.

Transpl Infect Dis. 2016 Jun;18(3):361-71. doi: 10.1111/tid.12530. Epub 2016 May 17.

PMID:
26998753
20.

Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria.

Redfield RR, Ellis TM, Zhong W, Scalea JR, Zens TJ, Mandelbrot D, Muth BL, Panzer S, Samaniego M, Kaufman DB, Astor BC, Djamali A.

Hum Immunol. 2016 Apr;77(4):346-52. doi: 10.1016/j.humimm.2016.01.018. Epub 2016 Feb 9.

PMID:
26867813
21.

In Kidney Transplant Recipients With a Positive Virtual Crossmatch, High PRA was Associated With Lower Incidence of Viral Infections.

Parajuli S, Muth BL, Turk JA, Astor BC, Mohammed M, Mandelbrot DA, Djamali A.

Transplantation. 2016 Mar;100(3):655-61. doi: 10.1097/TP.0000000000001061.

PMID:
26760571
22.

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K; CKD Prognosis Consortium.

JAMA. 2016 Jan 12;315(2):164-74. doi: 10.1001/jama.2015.18202. Erratum in: JAMA. 2016 Feb 23;315(8):822.

23.

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.

Gori M, Gupta DK, Claggett B, Selvin E, Folsom AR, Matsushita K, Bello NA, Cheng S, Shah A, Skali H, Vardeny O, Ni H, Ballantyne CM, Astor BC, Klein BE, Aguilar D, Solomon SD.

Diabetes Care. 2016 May;39(5):677-85. doi: 10.2337/dc15-1760. Epub 2016 Jan 6.

24.

Erosion of the Silicone Peritoneal Dialysis Catheter with the Use of Gentamicin Cream at the Exit Site.

Gardezi AI, Schlageter KW, Foster DM, Astor BC, Chan MR, Waheed S.

Adv Perit Dial. 2016;32:15-18.

PMID:
28988584
25.
26.

Outpatient Management of Delayed Graft Function Is Associated With Reduced Length of Stay Without an Increase in Adverse Events.

Muth BL, Astor BC, Turk J, Mohamed M, Parajuli S, Kaufman DB, Mandelbrot DA, Djamali A.

Am J Transplant. 2016 May;16(5):1604-11. doi: 10.1111/ajt.13689. Epub 2016 Mar 11.

27.

The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).

Shin JI, Palta M, Djamali A, Kaufman DB, Astor BC.

Transplantation. 2016 Jul;100(7):1541-9. doi: 10.1097/TP.0000000000000938.

PMID:
26566058
28.

Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.

Lazo M, Halushka MK, Shen L, Maruthur N, Rebholz CM, Rawlings AM, Hoogeveen RC, Brinkley TE, Ballantyne CM, Astor BC, Selvin E.

Am Heart J. 2015 Nov;170(5):961-7. doi: 10.1016/j.ahj.2015.08.008. Epub 2015 Aug 14.

29.

Predictors and outcomes of delayed graft function after living-donor kidney transplantation.

Redfield RR, Scalea JR, Zens TJ, Muth B, Kaufman DB, Djamali A, Astor BC, Mohamed M.

Transpl Int. 2016 Jan;29(1):81-7. doi: 10.1111/tri.12696. Epub 2015 Oct 26.

30.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

31.

Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study.

Schneider AL, Jonassaint C, Sharrett AR, Mosley TH, Astor BC, Selvin E, Coresh J, Gottesman RF.

J Gerontol A Biol Sci Med Sci. 2016 Jun;71(6):772-9. doi: 10.1093/gerona/glv158. Epub 2015 Sep 11.

32.

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.

Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML.

Am J Nephrol. 2015;42(1):25-34. doi: 10.1159/000438999. Epub 2015 Aug 20.

33.

Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsy.

Redfield RR, McCune KR, Rao A, Sadowski E, Hanson M, Kolterman AJ, Robbins J, Guite K, Mohamed M, Parajuli S, Mandelbrot DA, Astor BC, Djamali A.

Transpl Int. 2016 Feb;29(2):167-72. doi: 10.1111/tri.12660.

34.

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.

Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group.

PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.

35.

Percutaneous versus surgical insertion of PD catheters in dialysis patients: a meta-analysis.

Boujelbane L, Fu N, Chapla K, Melnick D, Redfield RR, Waheed S, Yevzlin AS, Shin JI, Astor BC, Chan MR.

J Vasc Access. 2015 Nov-Dec;16(6):498-505. doi: 10.5301/jva.5000439. Epub 2015 Jun 29. Review.

PMID:
26165817
36.

Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Alexander N, Matsushita K, Sang Y, Ballew S, Mahmoodi BK, Astor BC, Coresh J.

Am J Nephrol. 2015;41(4-5):409-17. doi: 10.1159/000433450. Epub 2015 Jun 30.

37.

The effects of weight change on glomerular filtration rate.

Chang A, Greene TH, Wang X, Kendrick C, Kramer H, Wright J, Astor B, Shafi T, Toto R, Lewis J, Appel LJ, Grams M.

Nephrol Dial Transplant. 2015 Nov;30(11):1870-7. doi: 10.1093/ndt/gfv219. Epub 2015 Jun 17.

38.

Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study.

Maruthur NM, Li M, Halushka MK, Astor BC, Pankow JS, Boerwinkle E, Coresh J, Selvin E, Kao WH.

PLoS One. 2015 Jun 17;10(6):e0128452. doi: 10.1371/journal.pone.0128452. eCollection 2015.

39.

Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Fornage M, Parekh RS, Coresh J, Kao WH.

Clin J Am Soc Nephrol. 2015 May 7;10(5):784-90. doi: 10.2215/CJN.08340814. Epub 2015 Apr 17.

40.

Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Chen TK, Estrella MM, Astor BC, Greene T, Wang X, Grams ME, Appel LJ.

Nephrol Dial Transplant. 2015 Aug;30(8):1329-35. doi: 10.1093/ndt/gfv037. Epub 2015 Mar 27.

41.

Prediction of Arteriovenous Fistula Dysfunction: Can it be Taught?

Rosenberg JE, Yevzlin AS, Chan MR, Valliant AM, Astor BC.

Semin Dial. 2015 Sep-Oct;28(5):544-7. doi: 10.1111/sdi.12361. Epub 2015 Mar 20.

PMID:
25800820
42.

Alternative strategies needed to improve vascular access outcomes.

Yevzlin AS, Astor BC.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):172-3. doi: 10.2215/CJN.12501214. Epub 2015 Jan 13. No abstract available.

43.

sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.

Al Rifai M, Schneider AL, Alonso A, Maruthur N, Parrinello CM, Astor BC, Hoogeveen RC, Soliman EZ, Chen LY, Ballantyne CM, Halushka MK, Selvin E.

J Diabetes Complications. 2015 Mar;29(2):180-5. doi: 10.1016/j.jdiacomp.2014.11.008. Epub 2014 Nov 25.

44.

Effect of renal function on prognosis in chronic heart failure.

Löffler AI, Cappola TP, Fang J, Hetzel SJ, Kadlec A, Astor B, Sweitzer NK.

Am J Cardiol. 2015 Jan 1;115(1):62-8. doi: 10.1016/j.amjcard.2014.09.055. Epub 2014 Oct 23.

45.

Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).

Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ.

Am J Kidney Dis. 2015 Mar;65(3):394-402. doi: 10.1053/j.ajkd.2014.07.026. Epub 2014 Oct 14.

46.

Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease).

Szczech LA, Stewart RC, Su HL, DeLoskey RJ, Astor BC, Fox CH, McCullough PA, Vassalotti JA.

PLoS One. 2014 Nov 26;9(11):e110535. doi: 10.1371/journal.pone.0110535. eCollection 2014.

47.

A Meta-analysis of Stent Placement vs. Angioplasty for Dialysis Vascular Access Stenosis.

Fu N, Joachim E, Yevzlin AS, Shin JI, Astor BC, Chan MR.

Semin Dial. 2015 May-Jun;28(3):311-7. doi: 10.1111/sdi.12314. Epub 2014 Oct 9.

PMID:
25303220
48.

Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease.

Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Selvin E, Coresh J, Kao WH.

Kidney Int. 2015 Apr;87(4):820-7. doi: 10.1038/ki.2014.331. Epub 2014 Oct 1.

49.

Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Banerjee T, Kim SJ, Astor B, Shafi T, Coresh J, Powe NR.

Am J Kidney Dis. 2014 Dec;64(6):954-61. doi: 10.1053/j.ajkd.2014.07.010. Epub 2014 Sep 27.

50.

Hemodialysis catheter locking solutions and the prevention of catheter dysfunction: a meta-analysis.

Chapla K, Oza-Gajera BP, Yevzlin AS, Shin JI, Astor BC, Chan MR.

J Vasc Access. 2015 Mar-Apr;16(2):107-12. doi: 10.5301/jva.5000312. Epub 2014 Sep 27.

PMID:
25262758

Supplemental Content

Support Center